<?xml version="1.0" ?>
<document id="aae1603af1bb84087248441716a5c0bd373603b7">
  <chunk id="aae1603af1bb84087248441716a5c0bd373603b7.c0" text="H1N1pdm09 Adjuvanted Vaccination in HIV-Infected Adults: A Randomized Trial of Two Single versus Two Double Doses"/>
  <chunk id="aae1603af1bb84087248441716a5c0bd373603b7.c1" text="Background: Since human immunodeficiency virus (HIV)-infected individuals are at increased risk of severe disease from pandemic influenza A (H1N1pdm09), vaccination was recommended as a prevention strategy. The aim of the present study was to evaluate the safety, immunogenicity and persistence of the immune response after vaccination against pandemic influenza A (H1N1pdm09) with an adjuvanted vaccine in human immunodeficiency virus (HIV)-infected adults using two single and two double doses.">
    <entity charOffset="24-40" id="aae1603af1bb84087248441716a5c0bd373603b7.c1.e0" ontology_id="HP_0002721" text="immunodeficiency" type="phenotype"/>
    <entity charOffset="99-105" id="aae1603af1bb84087248441716a5c0bd373603b7.c1.e1" ontology_id="HP_0012828" text="severe" type="phenotype"/>
    <entity charOffset="302-317" id="aae1603af1bb84087248441716a5c0bd373603b7.c1.e2" ontology_id="GO_0006955" text="immune response" type="gene_function"/>
    <entity charOffset="413-429" id="aae1603af1bb84087248441716a5c0bd373603b7.c1.e3" ontology_id="HP_0002721" text="immunodeficiency" type="phenotype"/>
    <pair e1="aae1603af1bb84087248441716a5c0bd373603b7.c1.e0" e2="aae1603af1bb84087248441716a5c0bd373603b7.c1.e2" id="aae1603af1bb84087248441716a5c0bd373603b7.c1.p0" relation="true"/>
    <pair e1="aae1603af1bb84087248441716a5c0bd373603b7.c1.e1" e2="aae1603af1bb84087248441716a5c0bd373603b7.c1.e2" id="aae1603af1bb84087248441716a5c0bd373603b7.c1.p1" relation="true"/>
    <pair e1="aae1603af1bb84087248441716a5c0bd373603b7.c1.e2" e2="aae1603af1bb84087248441716a5c0bd373603b7.c1.e3" id="aae1603af1bb84087248441716a5c0bd373603b7.c1.p2" relation="true"/>
  </chunk>
</document>
